
Khatol S. Shahnan Shah
Examiner (ID: 11599, Phone: (571)272-0863 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 690 |
| Issued Applications | 341 |
| Pending Applications | 102 |
| Abandoned Applications | 265 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5912848
[patent_doc_number] => 20060127910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Bpl1 as an antifungal target'
[patent_app_type] => utility
[patent_app_number] => 10/537580
[patent_app_country] => US
[patent_app_date] => 2003-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7012
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127910.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537580 | Bpl1 as an antifungal target | Dec 8, 2003 | Abandoned |
Array
(
[id] => 81307
[patent_doc_number] => 07745198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Method of producing macrolide compound'
[patent_app_type] => utility
[patent_app_number] => 10/532412
[patent_app_country] => US
[patent_app_date] => 2003-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10221
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745198.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532412
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532412 | Method of producing macrolide compound | Nov 26, 2003 | Issued |
Array
(
[id] => 5710475
[patent_doc_number] => 20060051820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Method of examing staphylococcus aureus'
[patent_app_type] => utility
[patent_app_number] => 10/535917
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3657
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535917
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535917 | Method of examing staphylococcus aureus | Nov 20, 2003 | Abandoned |
Array
(
[id] => 5820452
[patent_doc_number] => 20060024765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Method of inspecting staphylococcus aureus'
[patent_app_type] => utility
[patent_app_number] => 10/535915
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3668
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024765.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535915
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535915 | Method of inspecting staphylococcus aureus | Nov 20, 2003 | Abandoned |
Array
(
[id] => 101871
[patent_doc_number] => 07722882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Live attenuated vaccine against porcine pleuropneumonia'
[patent_app_type] => utility
[patent_app_number] => 10/535416
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10514
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/722/07722882.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535416
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535416 | Live attenuated vaccine against porcine pleuropneumonia | Nov 16, 2003 | Issued |
| 10/475688 | ANTI-OBESITY POLYPEPTIDES | Oct 19, 2003 | Abandoned |
Array
(
[id] => 7208765
[patent_doc_number] => 20050043525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'GlutRNAGln amidotransferase - a novel essential translational component'
[patent_app_type] => utility
[patent_app_number] => 10/661399
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11241
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10661399
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/661399 | GlutRNAGln amidotransferase - a novel essential translational component | Sep 11, 2003 | Abandoned |
Array
(
[id] => 7225557
[patent_doc_number] => 20050255125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/524198
[patent_app_country] => US
[patent_app_date] => 2003-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8253
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255125.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524198
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524198 | Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine | Aug 5, 2003 | Issued |
Array
(
[id] => 7398882
[patent_doc_number] => 20040023255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Motor proteins and methods for their use'
[patent_app_type] => new
[patent_app_number] => 10/343729
[patent_app_country] => US
[patent_app_date] => 2003-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18494
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023255.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343729
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343729 | Motor proteins and methods for their use | Aug 3, 2003 | Abandoned |
Array
(
[id] => 190771
[patent_doc_number] => 07642082
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-01-05
[patent_title] => 'Methods for determining the presence of staphylococcal enterotoxin A gene in a sample'
[patent_app_type] => utility
[patent_app_number] => 10/631224
[patent_app_country] => US
[patent_app_date] => 2003-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7531
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 331
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/642/07642082.pdf
[firstpage_image] =>[orig_patent_app_number] => 10631224
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/631224 | Methods for determining the presence of staphylococcal enterotoxin A gene in a sample | Jul 27, 2003 | Issued |
Array
(
[id] => 7390030
[patent_doc_number] => 20040037835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Cytotoxic agents'
[patent_app_type] => new
[patent_app_number] => 10/614603
[patent_app_country] => US
[patent_app_date] => 2003-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7776
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20040037835.pdf
[firstpage_image] =>[orig_patent_app_number] => 10614603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/614603 | Cytotoxic agents | Jul 6, 2003 | Abandoned |
Array
(
[id] => 7356130
[patent_doc_number] => 20040013688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Vaccines to induce mucosal immunity'
[patent_app_type] => new
[patent_app_number] => 10/613975
[patent_app_country] => US
[patent_app_date] => 2003-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11644
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20040013688.pdf
[firstpage_image] =>[orig_patent_app_number] => 10613975
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/613975 | Vaccines to induce mucosal immunity | Jul 2, 2003 | Abandoned |
Array
(
[id] => 5632220
[patent_doc_number] => 20060148690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Secreted peptides'
[patent_app_type] => utility
[patent_app_number] => 10/521005
[patent_app_country] => US
[patent_app_date] => 2003-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 39706
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521005
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521005 | Secreted peptides | Jun 29, 2003 | Abandoned |
Array
(
[id] => 474355
[patent_doc_number] => 07226597
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-05
[patent_title] => 'Mutants of Clostridium difficile toxin B and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/463957
[patent_app_country] => US
[patent_app_date] => 2003-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10442
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/226/07226597.pdf
[firstpage_image] =>[orig_patent_app_number] => 10463957
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/463957 | Mutants of Clostridium difficile toxin B and methods of use | Jun 16, 2003 | Issued |
Array
(
[id] => 7392557
[patent_doc_number] => 20040038200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Distinguishing molecular forms'
[patent_app_type] => new
[patent_app_number] => 10/332778
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3915
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038200.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332778 | Distinguishing molecular forms | Jun 11, 2003 | Abandoned |
Array
(
[id] => 7313301
[patent_doc_number] => 20040033550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides'
[patent_app_type] => new
[patent_app_number] => 10/445461
[patent_app_country] => US
[patent_app_date] => 2003-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12966
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033550.pdf
[firstpage_image] =>[orig_patent_app_number] => 10445461
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/445461 | Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides | May 26, 2003 | Abandoned |
Array
(
[id] => 9817209
[patent_doc_number] => 08926992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-06
[patent_title] => 'Mucosal vaccines with chitosan adjuvant and meningococcal antigens'
[patent_app_type] => utility
[patent_app_number] => 10/514207
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 9459
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10514207
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514207 | Mucosal vaccines with chitosan adjuvant and meningococcal antigens | May 13, 2003 | Issued |
Array
(
[id] => 5873043
[patent_doc_number] => 20060165730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Polysaccharide and glycoconjugate vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/513178
[patent_app_country] => US
[patent_app_date] => 2003-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5616
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20060165730.pdf
[firstpage_image] =>[orig_patent_app_number] => 10513178
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/513178 | Polysaccharide and glycoconjugate vaccines | May 6, 2003 | Issued |
Array
(
[id] => 856617
[patent_doc_number] => 07374874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-20
[patent_title] => 'Bacteriophages that infect Bacillus bacteria (Anthrax)'
[patent_app_type] => utility
[patent_app_number] => 10/420530
[patent_app_country] => US
[patent_app_date] => 2003-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 25
[patent_no_of_words] => 19676
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/374/07374874.pdf
[firstpage_image] =>[orig_patent_app_number] => 10420530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/420530 | Bacteriophages that infect Bacillus bacteria (Anthrax) | Apr 21, 2003 | Issued |
Array
(
[id] => 411463
[patent_doc_number] => 07282369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-16
[patent_title] => 'Tests for the rapid evaluation of ischemic states and kits'
[patent_app_type] => utility
[patent_app_number] => 10/414469
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 21662
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/282/07282369.pdf
[firstpage_image] =>[orig_patent_app_number] => 10414469
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/414469 | Tests for the rapid evaluation of ischemic states and kits | Apr 14, 2003 | Issued |